{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_ezetimibe",
          "name": "Ezetimibe"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_lomitapide",
          "name": "Lomitapide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_pcsk9_inhibitors",
          "name": "PCSK9 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_triglyceride_lowering_agents",
          "name": "Triglyceride-lowering agents"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_cetilistat",
          "name": "Cetilistat"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_orlistat",
          "name": "Orlistat"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_bempedoic_acid",
          "name": "Bempedoic acid"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sofosbuvir",
          "name": "Sofosbuvir"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [],
    "ranking": [],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_fibrates",
          "type": "Drug",
          "label": "Fibrates",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_omega_3_fatty_acids",
          "type": "Drug",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_statins",
          "type": "Drug",
          "label": "Statins",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ezetimibe",
          "type": "Drug",
          "label": "Ezetimibe",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lomitapide",
          "type": "Drug",
          "label": "Lomitapide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_pcsk9_inhibitors",
          "type": "Drug",
          "label": "PCSK9 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_triglyceride_lowering_agents",
          "type": "Drug",
          "label": "Triglyceride-lowering agents",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_severe_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_lipid_metabolism",
          "type": "Pathway",
          "label": "Lipid metabolism",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_ppar_alpha",
          "type": "Target",
          "label": "PPAR-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_lpl",
          "type": "Target",
          "label": "Lipoprotein lipase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_improved_lipid_profile",
          "type": "Phenotype",
          "label": "Improved lipid profile",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_fibrates",
          "type": "Target",
          "label": "Fibrates Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_fibrates",
          "type": "Pathway",
          "label": "Fibrates Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_fibrates",
          "type": "Phenotype",
          "label": "Adverse Effects of Fibrates",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_niacin",
          "type": "Target",
          "label": "Niacin Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_niacin",
          "type": "Pathway",
          "label": "Niacin Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_niacin",
          "type": "Phenotype",
          "label": "Adverse Effects of Niacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_omega_3",
          "type": "Target",
          "label": "Omega-3 Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_omega_3",
          "type": "Pathway",
          "label": "Omega-3 Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_omega_3",
          "type": "Phenotype",
          "label": "Adverse Effects of Omega-3",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_statins",
          "type": "Target",
          "label": "Statins Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_statins",
          "type": "Pathway",
          "label": "Statins Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_statins",
          "type": "Phenotype",
          "label": "Adverse Effects of Statins",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Fibrates",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Niacin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Statins",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Ezetimibe",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Lomitapide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "PCSK9 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Triglyceride-lowering agents",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Cetilistat",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cetilistat",
          "type": "Drug",
          "label": "Cetilistat",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Orlistat",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_orlistat",
          "type": "Drug",
          "label": "Orlistat",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Bempedoic acid",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bempedoic_acid",
          "type": "Drug",
          "label": "Bempedoic acid",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Sofosbuvir",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_sofosbuvir",
          "type": "Drug",
          "label": "Sofosbuvir",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_fibrates",
          "target": "target_ppar_alpha",
          "relation": "activates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知对 PPAR-alpha 的活化作用"
        },
        {
          "source": "drug_niacin",
          "target": "target_lpl",
          "relation": "activates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "强化脂蛋白酯酶活性"
        },
        {
          "source": "drug_omega_3_fatty_acids",
          "target": "target_lpl",
          "relation": "activates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "常识：改善甘油三酯代谢"
        },
        {
          "source": "drug_statins",
          "target": "pathway_lipid_metabolism",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "普遍应用于脂质代谢通路"
        },
        {
          "source": "drug_ezetimibe",
          "target": "pathway_lipid_metabolism",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通过抑制胆固醇吸收参与"
        },
        {
          "source": "drug_lomitapide",
          "target": "target_lpl",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "通过抑制 VLDL 产生作用"
        },
        {
          "source": "drug_pcsk9_inhibitors",
          "target": "target_lpl",
          "relation": "activates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "通过降低 LDL 受体降解"
        },
        {
          "source": "drug_triglyceride_lowering_agents",
          "target": "pathway_lipid_metabolism",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "针对甘油三酯代谢的综合治疗"
        },
        {
          "source": "target_ppar_alpha",
          "target": "phenotype_improved_lipid_profile",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "PPAR-alpha 通路影响血脂"
        },
        {
          "source": "target_lpl",
          "target": "phenotype_improved_lipid_profile",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响甘油三酯清除"
        },
        {
          "source": "pathway_lipid_metabolism",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "脂质代谢失常与病症关联"
        },
        {
          "source": "phenotype_improved_lipid_profile",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "改善表型可降低疾病风险"
        },
        {
          "source": "drug_fibrates",
          "target": "n_ot_fibrates",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能存在副作用相关的离靶作用"
        },
        {
          "source": "n_ot_fibrates",
          "target": "n_rp_fibrates",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致风险通路活化"
        },
        {
          "source": "n_rp_fibrates",
          "target": "n_adv_fibrates",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在导致不良反应"
        },
        {
          "source": "n_adv_fibrates",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险存在，可能抵消治疗获益"
        },
        {
          "source": "drug_niacin",
          "target": "n_ot_niacin",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能存在副作用相关的离靶作用"
        },
        {
          "source": "n_ot_niacin",
          "target": "n_rp_niacin",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致风险通路活化"
        },
        {
          "source": "n_rp_niacin",
          "target": "n_adv_niacin",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "潜在导致不良反应"
        },
        {
          "source": "n_adv_niacin",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险存在，可能抵消治疗获益"
        },
        {
          "source": "drug_omega_3_fatty_acids",
          "target": "n_ot_omega_3",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在副作用相关的离靶作用"
        },
        {
          "source": "n_ot_omega_3",
          "target": "n_rp_omega_3",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致风险通路活化"
        },
        {
          "source": "n_rp_omega_3",
          "target": "n_adv_omega_3",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在导致不良反应"
        },
        {
          "source": "n_adv_omega_3",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险存在，可能抵消治疗获益"
        },
        {
          "source": "drug_statins",
          "target": "n_ot_statins",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "可能存在副作用相关的离靶作用"
        },
        {
          "source": "n_ot_statins",
          "target": "n_rp_statins",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "离靶作用可能导致风险通路活化"
        },
        {
          "source": "n_rp_statins",
          "target": "n_adv_statins",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "潜在导致不良反应"
        },
        {
          "source": "n_adv_statins",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险存在，可能抵消治疗获益"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H1_round3",
        "key_assumptions": [
          "Fibrates 通过 PPAR-alpha 激活影响脂质代谢",
          "处理潜在副作用的风险路径已被明确"
        ],
        "caveats": [
          "副作用可能抵消治疗获益"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "score": 0.73,
        "graph_snapshot_ref": "GE_H2_round3",
        "key_assumptions": [
          "Niacin 通过强化脂蛋白酯酶活性改善甘油三酯水平",
          "副作用风险已被识别并评估"
        ],
        "caveats": [
          "风险可能会影响治疗的整体效果"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "score": 0.7,
        "graph_snapshot_ref": "GE_H3_round3",
        "key_assumptions": [
          "Omega-3 改善甘油三酯代谢机制得到验证",
          "潜在副作用风险已考虑"
        ],
        "caveats": [
          "可能引起的不良反应需进一步研究"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "score": 0.68,
        "graph_snapshot_ref": "GE_H4_round3",
        "key_assumptions": [
          "Statins 的脂质代谢机制广泛认同",
          "副作用及风险路径有明确标注"
        ],
        "caveats": [
          "治疗效果可能受到副作用影响"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target→Phenotype",
          "reason": "已建立有效的治疗通路并考虑副作用"
        }
      ],
      "remaining_gaps": [
        "需要更深入研究以识别和证实副作用的临床影响"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C"
          ],
          "impact_summary": "提高了作用机制的多样性，并强化了联通路径"
        },
        {
          "round": 2,
          "seeds": [
            "D",
            "E"
          ],
          "impact_summary": "增强了对已知副作用的理解"
        }
      ],
      "lessons": [
        "同时关注机制和副作用有助于形成更全面的治疗建议",
        "在缺乏明确证据时，引入更多样化的候选药物以涵盖不同路径"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "应注意副作用的识别和处理，同时增加对不同机制的综合考量"
      },
      {
        "role": "Skeptic",
        "patch": "确保所有潜在副作用通过高权重边被标注并关注其对治疗的影响"
      },
      {
        "role": "Explorer",
        "patch": "优先探索具有不同作用机制的候选药物，并覆盖新的药物类别"
      }
    ],
    "heuristics": [
      {
        "when": "存在顽固性高甘油三酯",
        "then": "评估多种药物的潜在相互作用和个体风险"
      }
    ]
  }
}